Executive committee
Guiding Science with Vision, Integrity, and Experience.
JY BioMed is led by a multidisciplinary team of scientific, clinical, and strategic experts committed to translating research into real-world impact. With decades of combined experience across immunotherapy, regenerative medicine, and biologic drug development, our leadership is focused on building robust, scalable platforms that can meet both medical and regulatory standards.
Patrick Hafenstein
Chairman
Ethan Shen, PhD
Chief Technology Officer
Adam Chen, PhD
Chief Executive Officer
Benjamin Zhang, MD
Chief Medical Officer
Advisory board
Shaping Strategy with Insight and Experience.
JY BioMed’s Advisory Board includes distinguished experts in translational medicine and medical neuroscience. Their guidance bridges scientific discovery with clinical application, reinforcing our mission to deliver impactful and patient-centered innovations.
Tsung-I Hsu, PhD
Medical Neuroscience
Chris Wu, PhD
Translational Medicine